TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›ZYME›Financials
Annual statements · SEC XBRL · FY2020 – FY2025

Zymeworks Inc. (ZYME) financials

Income statement

Zymeworks Inc. (ZYME) income statement, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Revenue$39.0M$26.7M$412M$76.0M$76.3M$106M
Revenue growth—-31.5%1446.0%-81.6%0.4%38.9%
Operating income-$187M-$216M$131M-$138M-$137M-$92.5M
Operating margin-481.3%-808.2%31.6%-181.6%-179.7%-87.3%
Net income-$181M-$212M$124M-$119M-$123M-$81.1M
Net margin-463.5%-794.0%30.1%-156.1%-160.8%-76.6%
EPS (diluted)-$3.58-$4.61$1.90-$1.72-$1.62-$1.08

Cash flow

Zymeworks Inc. (ZYME) cash flow, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$151M-$192M$144M-$118M-$110M-$33.0M
Capital expenditures$4.31M$12.4M$8.15M$2.47M$1.99M$1.52M
Free cash flow-$156M-$205M$136M-$121M-$112M-$34.5M
Share buybacks——$0.00$0.00$30.1M$41.7M

Balance sheet

Zymeworks Inc. (ZYME) balance sheet, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$242M$202M$401M$158M$66.1M$41.2M
Total assets—$389M$649M$581M$463M$347M
Total liabilities—$140M$156M$116M$124M$78.0M
Shareholders' equity$410M$249M$493M$465M$339M$269M
Retained earnings—-$683M-$559M-$677M-$830M-$953M
Shares (wtd avg diluted)50.4M52.1M65.2M68.9M75.9M75.4M

Every figure is extracted from Zymeworks Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is Zymeworks Inc.'s annual revenue?
Zymeworks Inc. (ZYME) reported $106M of revenue for fiscal year 2025 — up 38.9% from $76.3M in FY2024, per its annual report filed with the SEC.
Is Zymeworks Inc. profitable?
Not in FY2025 — ZYME reported a net loss of $81.1M, per SEC filings.
What is Zymeworks Inc.'s free cash flow?
-$34.5M in FY2025 (operating cash flow -$33.0M minus $1.52M of capital expenditures), from the SEC cash-flow statement.
Does ZYME pay a dividend?
Zymeworks Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full ZYME analysis — verdict, score & filings →Is ZYME a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.